Clinical trial Recruiting at 1 site Observational Ages 40 and up

ShuntCheck vs radionuclide shunt testing for suspected obstruction in adults with normal pressure hydrocephalus

Official title: Diagnostic Accuracy of ShuntCheck Compared With Radionuclide Shunt Patency Test to Detect Shunt Flow Obstruction in Patients With Normal Pressure Hydrocephalus - A Cross-sectional Analytic Study

Run by University of South Florida · NCT04309487 · Data updated 2026-11-12

This study tests whether ShuntCheck can accurately detect CSF shunt flow issues in adults with suspected shunt obstruction due to normal pressure hydrocephalus.

Quick facts

Study typeObservational
Ages40 Years and up
SexAll
Enrollment20 (estimated)
SponsorUniversity of South Florida
Academic / other
Locations1 site (Tampa, Florida)
StatusRecruiting
StartedJanuary 24, 2020
Main results expectedJanuary 2027
Study endsJanuary 2027
Registry record updatedMay 18, 2026
Trial IDNCT04309487 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 40 years and older with a VP shunt for normal pressure hydrocephalus and suspected shunt obstruction.

Probably not a fit

Patients without suspected shunt obstruction or those not meeting the age or device criteria may not benefit from this testing.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study compares the diagnostic accuracy of ShuntCheck to radionuclide shunt patency testing in patients with normal pressure hydrocephalus and suspected shunt obstruction. Participants are adults aged 40 and older with a ventriculoperitoneal shunt. The study analyzes how well ShuntCheck identifies shunt patency or obstruction relative to the standard SPS method. It focuses on measuring sensitivity and specificity in detecting CSF flow through the shunt. The lead site is the University of South Florida, with NeuroDx Development as a collaborator.

Why it matters

Potential benefit: If successful, ShuntCheck could provide a rapid, noninvasive test to help clinicians determine shunt status and guide management.

How similar studies have gone: Previous work has explored ShuntCheck techniques in shunt assessment, but direct comparison to radionuclide testing in NPH obstruction remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men or women 40 yo or older and have a VP shunt placed for NPH and are suspected of shunt obstruction.
* Capable of providing valid signed informed consent, or has a legal guardian, health care agent, or surrogate decision maker (according to local statutes, and collectively referred to as "surrogates" in this protocol) capable of providing valid, signed informed consent

Exclusion Criteria:

* Presence of multiple shunts, or presence of more than one distal shunt catheter (regardless of function) crossing the clavicle ipsilateral to the shunt with suspected obstruction;
* ShuntCheck test would interfere with standard patient care, or emergency shunt surgery that cannot be delayed is indicated;
* Presence of an interfering open wound or edema over any portion of the VP shunt.

Where it's running

  • University of South Florida Department of Neurological Surgery and Brain Repair
    Tampa, Florida, United States
    Recruiting

Study contacts

  • Principal investigator: Naomi Abel, MD — University of South Florida
  • Study coordinator: Naomi Abel, MD
  • Email: nabel@usf.edu
  • Phone: 813 259-0904

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.